SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-133959
Filing Date
2020-12-10
Accepted
2020-12-10 08:21:02
Documents
13
Period of Report
2020-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2038162d2_8k.htm   iXBRL 8-K 36815
2 EXHIBIT 99.1 tm2038162d2_ex99-1.htm EX-99.1 29859
  Complete submission text file 0001104659-20-133959.txt   254737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neos-20201210.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neos-20201210_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neos-20201210_pre.xml EX-101.PRE 22706
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2038162d2_8k_htm.xml XML 3612
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37508 | Film No.: 201379535
SIC: 2834 Pharmaceutical Preparations